This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: The Innovations of Hans Yssel
Introduction
Hans Yssel is a notable inventor based in Paris, France. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning chronic pathologies such as Lyme disease. His work has implications for both diagnosis and therapeutic approaches, showcasing his innovative spirit and dedication to improving patient care.
Latest Patents
Hans Yssel holds a patent related to the diagnostic and treatment of chronic pathologies, specifically Lyme disease. The patent focuses on several biomarkers, including IL-1RA, IFN-γ, and GM-CSF, whose expressions at both the mRNA and protein levels correlate with chronic conditions. This invention provides methods and kits for diagnosing such chronic pathologies and assessing a patient's response to treatment. Additionally, it includes methods and therapeutic agents for treating these chronic conditions.
Career Highlights
Throughout his career, Hans Yssel has worked with prestigious institutions, including the National Centre for Scientific Research (Centre National De La Recherche Scientifique) and the National Institute of Health and Medical Research. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Hans has collaborated with notable colleagues such as Hugues Gascan and Sylvie Chevalier. Their combined expertise has further advanced the understanding and treatment of chronic diseases.
Conclusion
Hans Yssel's innovative contributions to the field of medical diagnostics and treatment highlight his commitment to addressing chronic pathologies. His work continues to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile